MLR

OSCAR HEALTH INVESTORS: July 11, 2022 Filing Deadline in Securities Class Action – Contact Lieff Cabraser

Retrieved on: 
Tuesday, May 17, 2022 - 2:00pm

A lead plaintiff is a representative party who acts on behalf of other class members in directing the litigation.

Key Points: 
  • A lead plaintiff is a representative party who acts on behalf of other class members in directing the litigation.
  • You may retain Lieff Cabraser, or other attorneys, as your counsel in the action.
  • In March 2021, Oscar Health completed its IPO, selling 36 million shares of Class A common stock at $39 per share, for proceeds of approximately $1.3 billion.
  • The National Law Journal has recognized Lieff Cabraser as one of the nations top plaintiffs law firms for fourteen years.

Shareholder Alert: Robbins LLP informs Shareholders of Class Action Against Oscar Health, Inc.  

Retrieved on: 
Tuesday, May 17, 2022 - 8:21am

The Class: Shareholder rights law firm Robbins LLP informs investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired Oscar Health, Inc. (NYSE: OSCR) securities pursuant to the Company's March 2021 initial public offering ("IPO").

Key Points: 
  • The Class: Shareholder rights law firm Robbins LLP informs investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired Oscar Health, Inc. (NYSE: OSCR) securities pursuant to the Company's March 2021 initial public offering ("IPO").
  • Oscar Health is a health insurance company that claims to be the first company "built around a full stack technology platform."
  • If you would like more information about Oscar Health, Inc.'s misconduct, click here .
  • Specifically, it omitted to state that Oscar was experiencing growing COVID-19 testing and treatment costs as well as growing net COVID-19 costs.

OSCAR ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Oscar Health, Inc. and Encourages Investors to Contact the Firm

Retrieved on: 
Tuesday, May 17, 2022 - 2:00am

Investors have until July 12, 2022 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

Key Points: 
  • Investors have until July 12, 2022 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
  • In March 2021, Oscar conducted its IPO, selling 36,391,946 shares of Class A common stock at a price of $39.00 per share.
  • The Company also disclosed that its net loss for the quarter was $73.1 million, an increase of $32.1 million year-over-year.
  • Then, on November 10, 2021, Oscar disclosed that its third quarter 2021 MLR increased 920 basis points year-over-year, to 99.7%.

The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Oscar Health, Inc. (OSCR) Investors

Retrieved on: 
Monday, May 16, 2022 - 5:05pm

Oscar investors have until July 11, 2022, to file a lead plaintiff motion.

Key Points: 
  • Oscar investors have until July 11, 2022, to file a lead plaintiff motion.
  • In March 2021, Oscar conducted its IPO, selling 36,391,946 shares of Class A common stock at a price of $39.00 per share.
  • On November 10, 2021, Oscar disclosed that its third quarter 2021 medical loss ratio (MLR) increased 920 basis points year-over-year, to 99.7%.
  • The Company also disclosed that its net loss for the quarter was $212.7 million, an increase of $133.6 million year-over-year.

OSCAR HEALTH, INC. (NYSE: OSCR) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Oscar Health, Inc. (NYSE: OSCR)

Retrieved on: 
Saturday, May 14, 2022 - 6:30am

NEW YORK, May 14, 2022 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class action lawsuit that has been filed on behalf of investors who purchased or otherwise acquired the common stock of Oscar Health, Inc. (“Oscar” or the “Company”) (NYSE: OSCR) pursuant to and/or traceable to the registration statement and prospectus (collectively, the “Registration Statement”) issued in connection with the Company’s March 2021 initial public offering (“IPO” or the “Offering”). The lawsuit was filed in the United States District Court for the Southern District of New York and alleges violations of the Securities Exchange Act of 1933.

Key Points: 
  • Shareholder Class Action Lawsuit or contact Peter Allocco at (212) 951-2030 or pallocco@bernlieb.com to discuss your rights.
  • The lawsuit was filed in the United States District Court for the Southern District of New York and alleges violations of the Securities Exchange Act of 1933.
  • In March 2021, Oscar conducted its IPO, selling 36,391,946 shares of Class A common stock at a price of $39.00 per share.
  • The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414.

INVESTOR ALERT: Oscar Health, Inc. Investors with Substantial Losses Have Opportunity to Lead the Oscar Health Class Action Lawsuit - OSCR

Retrieved on: 
Saturday, May 14, 2022 - 12:21am

Lead plaintiff motions for the Oscar Health class action lawsuit must be filed with the court no later than July 11, 2022.

Key Points: 
  • Lead plaintiff motions for the Oscar Health class action lawsuit must be filed with the court no later than July 11, 2022.
  • A lead plaintiff acts on behalf of all other class members in directing the Oscar Health class action lawsuit.
  • The lead plaintiff can select a law firm of its choice to litigate the Oscar Health class action lawsuit.
  • An investors ability to share in any potential future recovery of the Oscar Health class action lawsuit is not dependent upon serving as lead plaintiff.

INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Oscar Health, Inc. (OSCR) Investors

Retrieved on: 
Friday, May 13, 2022 - 7:28pm

Oscar investors have until July 11, 2022 to file a lead plaintiff motion.

Key Points: 
  • Oscar investors have until July 11, 2022 to file a lead plaintiff motion.
  • Investors suffering losses on their Oscar investments are encouraged to contact the Law Offices of Howard G. Smith to discuss their legal rights in this class action at 888-638-4847 or by email to howardsmith@howardsmithlaw.com .
  • In March 2021, Oscar conducted its IPO, selling 36,391,946 shares of Class A common stock at a price of $39.00 per share.
  • On November 10, 2021, Oscar disclosed that its third quarter 2021 medical loss ratio (MLR) increased 920 basis points year-over-year, to 99.7%.

OSCR CLASS ACTION NOTICE: Glancy Prongay & Murray LLP Files Securities Lawsuit Against Oscar Health, Inc.

Retrieved on: 
Friday, May 13, 2022 - 2:44am

Glancy Prongay & Murray LLP (GPM) announces that it has filed a class action lawsuit in the United States District Court for the Southern District of New York captioned Carpenter v. Oscar Health, Inc., et al., Case No.

Key Points: 
  • Glancy Prongay & Murray LLP (GPM) announces that it has filed a class action lawsuit in the United States District Court for the Southern District of New York captioned Carpenter v. Oscar Health, Inc., et al., Case No.
  • Plaintiff pursues claims under Sections 11 and 15 of the Securities Act of 1933 (the Securities Act).
  • Investors are hereby notified that they have 60 days from this notice to move the Court to serve as lead plaintiff in this action.
  • In March 2021, Oscar conducted its IPO, selling 36,391,946 shares of Class A common stock at a price of $39.00 per share.

Framework Solutions to Announce New Service Offerings at the 2022 Veeva Summit

Retrieved on: 
Monday, May 2, 2022 - 1:57pm

DANBURY, Conn., May 2, 2022 /PRNewswire/ -- Framework Solutions, LLC ("Frameworks" or the "Company"), a leading provider of compliance and technology services to the Life Sciences industry, is excited to announce its new Marketing Operations, Grants Management and Technology Service offerings at the Veeva Summit in Boston, MA on May 5, 2022.

Key Points: 
  • DANBURY, Conn., May 2, 2022 /PRNewswire/ -- Framework Solutions, LLC ("Frameworks" or the "Company"), a leading provider of compliance and technology services to the Life Sciences industry, is excited to announce its new Marketing Operations, Grants Management and Technology Service offerings at the Veeva Summit in Boston, MA on May 5, 2022.
  • "Veeva is a valued partner and making this announcement at the Veeva Summit emphasizes Frameworks' commitment to the continued success of our mutual client partners," said Marc Ioli, Director, Account Solutions.
  • "We are excited to announce that Framework Solutions now offers a full suite of Technology Services.
  • This expansion of our service offerings will provide full end-to-end technology services for our customers," said Michael Scalea, Executive Vice President, Technology Services.

Major League Rugby Signs Historic Partnership with TAPPP to Bring Gaming To Its Live Broadcasts

Retrieved on: 
Wednesday, April 6, 2022 - 2:06pm

NEW YORK, April 6, 2022 /PRNewswire/ -- TAPPP, a New York-based technology and marketing company enabling fan engagement and new audience development, announced today a multi-year, national partnership with Major League Rugby (MLR) and The Rugby Network (TRN). TAPPP's first-of-its-kind product will allow rugby fans across the U.S. to engage in live, on-screen betting transactions and gaming contests in a curated, seamless and uninterrupted experience on The Rugby Network.

Key Points: 
  • TAPPP's first-of-its-kind product will allow rugby fans across the U.S. to engage in live, on-screen betting transactions and gaming contests in a curated, seamless and uninterrupted experience on The Rugby Network.
  • TAPPP's partnership with MLR and TRN brings a level of innovation that has not yet debuted in the US sports landscape.
  • Major League Rugby is a professional sports league in its fifth season and represents the highest level of rugby competition in North America.
  • TRN is a collaboration between Major League Rugby and RugbyPass, the world's leading digital rugby publisher.